PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $16,000 | -20.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $20,000 | +33.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | +7.1% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $14,000 | +7.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $13,000 | -35.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $20,000 | -9.1% | 6,000 | -15.3% | 0.00% | 0.0% |
| Q2 2016 | $22,000 | -8.3% | 7,081 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $24,000 | -33.3% | 7,081 | -29.8% | 0.00% | -50.0% |
| Q4 2015 | $36,000 | -28.0% | 10,081 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $50,000 | -23.1% | 10,081 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $65,000 | -36.9% | 10,081 | -30.9% | 0.00% | -40.0% |
| Q1 2015 | $103,000 | -8.0% | 14,581 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $112,000 | +1300.0% | 14,581 | +1248.8% | 0.01% | – |
| Q3 2014 | $8,000 | -20.0% | 1,081 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $10,000 | +11.1% | 1,081 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $9,000 | 0.0% | 1,081 | 0.0% | 0.00% | – |
| Q4 2013 | $9,000 | 0.0% | 1,081 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $9,000 | +12.5% | 1,081 | 0.0% | 0.00% | – |
| Q2 2013 | $8,000 | – | 1,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |